3 results match your criteria: "University of Michigan Department of Radiation Oncology[Affiliation]"
Int J Radiat Oncol Biol Phys
January 2021
University of Michigan Department of Radiation Oncology, Ann Arbor, Michigan.
Purpose: Previous reports of stereotactic body radiation therapy (SBRT) for hepatocellular carcinoma (HCC) suggest unacceptably high rates of toxicity in patients with Child-Turcotte-Pugh (CTP) B liver disease. We hypothesized that an individualized adaptive treatment approach based on midtreatment liver function would maintain good local control while limiting toxicity in this population.
Methods And Materials: Patients with CTP-B liver disease and HCC were treated on prospective trials of individualized adaptive SBRT between 2006 and 2018.
Adv Radiat Oncol
December 2015
University of Michigan Department of Radiation Oncology, Ann Arbor, Michigan.
Purpose/objectives: We sought to assess the utility of docetaxel administered concurrently with salvage radiation therapy (SRT) following postprostatectomy biochemical failure (BF).
Methods And Materials: Men with postprostatectomy BF were accrued on a single-arm phase 2 clinical trial. SRT doses ranged from 64.
Am J Clin Oncol
August 2015
*Department of Radiation Oncology, University of Michigan †Department of Radiation Oncology, Ann Arbor Veterans Affairs Health Care System, University of Michigan, Ann Arbor, MI.
There is a systematic relationship between fatigue, sleep, and decreased quality of life in cancer patients, with notably poor sleep quality among many head and neck cancer patients during and after treatment. An often overlooked cause of sleep disturbance in this patient population is obstructive sleep apnea (OSA). This review explores the current literature on the prevalence and clinical correlates of OSA, management outcomes, and data on cytokine-mediated fatigue in OSA.
View Article and Find Full Text PDF